CompletedPhase 4

Levosimendan Versus Combination With Magnesium Sulphate on Spine Protection by NIRS in Infants Undergoing Coarctectomy

Egypt40 participantsStarted 2021-02-04

Plain-language summary

In pediatric patients ,undergoing elective surgical correction of aortic coarcatation one of our main concern is spinal cord protection .Our aim to study the protective effect of levosimendan versus its combination with magnesium sulphate .

Who can participate

Age range1 Day – 12 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Age group ranging from 0 to 12 months of both sexes. Aortic coarcatation eligible for correction Exclusion Criteria: Parents or guardian refusal. Age more than12 months. Significant left ventricular dysfunction Patient with Heart block Patient with pre-existing CNS disorder eg seizure Patient with renal or hepatic dysfunction

What they're measuring

Near Infrared Spectroscopy value

Timeframe: Perioperative(immediately before cross clamp,10&20 min after cross clamping Aorta)

Trial details

NCT IDNCT04330755

SponsorDalia Saad Abd-El Kader

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-03-30

View on ClinicalTrials.gov More Aortic Coarctation trials